28 related articles for article (PubMed ID: 1642080)
1. Surgical treatment of primary hyperaldosteronism.
Weigel RJ; Wells SA; Gunnells JC; Leight GS
Ann Surg; 1994 Apr; 219(4):347-52. PubMed ID: 8161259
[TBL] [Abstract][Full Text] [Related]
2. Effect of sodium restriction on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone, newly identified mineralocorticoids in man.
Takeda Y; Miyamori I; Takeda R; Lewicka S; Vecsei P
J Clin Endocrinol Metab; 1992 May; 74(5):1195-7. PubMed ID: 1569167
[TBL] [Abstract][Full Text] [Related]
3. Effect of aging on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone.
Takeda Y; Miyamori I; Yoneda T; Iki K; Takeda R
J Steroid Biochem Mol Biol; 1995 Apr; 52(4):383-6. PubMed ID: 7734407
[TBL] [Abstract][Full Text] [Related]
4. Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism.
Takeda Y; Bige K; Iwuanyanwu T; Lewicka S; Vecsei P; Abdelhamid S; Harnik M
Steroids; 1991 Nov; 56(11):566-70. PubMed ID: 1814024
[TBL] [Abstract][Full Text] [Related]
5. Effect of adrenocorticotropin stimulation on the synthesis of 19-noraldosterone in man.
Takeda Y; Miyamori I; Yoneda T; Furukawa K; Hatakeyama H; Inaba S; Ito Y; Takeda R; Mabuchi H
J Clin Endocrinol Metab; 1996 May; 81(5):1852-5. PubMed ID: 8626846
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
Takeda Y; Miyamori I; Iki K; Takeda R; Vecsei P
Acta Endocrinol (Copenh); 1992 Jun; 126(6):484-8. PubMed ID: 1642080
[TBL] [Abstract][Full Text] [Related]
7. Significance of 19-noraldosterone, a new mineralocorticoid, in clinical and experimental hypertension.
Takeda Y; Miyamori I; Takeda R
Steroids; 1995 Jan; 60(1):137-42. PubMed ID: 7792799
[TBL] [Abstract][Full Text] [Related]
8. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
Irony I; Kater CE; Biglieri EG; Shackleton CH
Am J Hypertens; 1990 Jul; 3(7):576-82. PubMed ID: 2194512
[TBL] [Abstract][Full Text] [Related]
9. [18-hydroxycorticosterone (18-OH -B)].
Izumi Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():322-7. PubMed ID: 16149520
[No Abstract] [Full Text] [Related]
10. [Diagnosis of primary hyperaldosteronism].
Diederich S; Bidlingmaier M; Quinkler M; Reincke M
Med Klin (Munich); 2007 Jan; 102(1):16-21. PubMed ID: 17221347
[TBL] [Abstract][Full Text] [Related]
11. [Primary hyperaldosteronism].
Opocher G; Rocco S; Carpené G; Armanini D; Mantero F
Minerva Endocrinol; 1995 Mar; 20(1):49-54. PubMed ID: 7651282
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
